Benzinga's Top Upgrades, Downgrades For October 14, 2020

Benzinga的頂級升級，2020年10月14日降級

Benzinga Real-time News · 2020/10/14 10:01

Upgrades

For AnaptysBio Inc (NASDAQ:ANAB), Guggenheim upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, AnaptysBio showed an EPS of $0.79, compared to $0.89 from the year-ago quarter. At the moment, the stock has a 52-week-high of 39.48 and a 52-week-low of 10.0. AnaptysBio closed at $17.76 at the end of the last trading period.
According to Loop Capital, the prior rating for American Eagle Outfitters Inc (NYSE:AEO) was changed from Sell to Hold. In the second quarter, American Eagle Outfitters showed an EPS of $0.03, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of 16.825 and a 52-week-low of 6.535. American Eagle Outfitters closed at $14.80 at the end of the last trading period.
According to UBS, the prior rating for Workday Inc (NASDAQ:WDAY) was changed from Sell to Neutral. In the second quarter, Workday showed an EPS of $0.84, compared to $0.44 from the year-ago quarter. The stock has a 52-week-high of 248.75 and a 52-week-low of 107.75. At the end of the last trading period, Workday closed at $232.90.
For AutoZone Inc (NYSE:AZO), Raymond James upgraded the previous rating of Outperform to the current rating Strong Buy. AutoZone earned $30.93 in the fourth quarter, compared to $20.95 in the year-ago quarter. The current stock performance of AutoZone shows a 52-week-high of 1274.4075 and a 52-week-low of 684.91. Moreover, at the end of the last trading period, the closing price was at $1165.71.
JP Morgan upgraded the previous rating for NIO Inc (NYSE:NIO) from Neutral to Overweight. NIO earned $0.15 in the second quarter, compared to $0.45 in the year-ago quarter. The current stock performance of NIO shows a 52-week-high of 22.59 and a 52-week-low of 1.36. Moreover, at the end of the last trading period, the closing price was at $21.61.
According to Jefferies, the prior rating for Beacon Roofing Supply Inc (NASDAQ:BECN) was changed from Hold to Buy. For the third quarter, Beacon Roofing Supply had an EPS of $1.01, compared to year-ago quarter EPS of $0.32. The stock has a 52-week-high of 37.06 and a 52-week-low of 11.665. At the end of the last trading period, Beacon Roofing Supply closed at $35.43.
For Theravance Biopharma Inc (NASDAQ:TBPH), Morgan Stanley upgraded the previous rating of Equal-Weight to the current rating Overweight. Theravance Biopharma earned $1.00 in the second quarter, compared to $0.72 in the year-ago quarter. At the moment, the stock has a 52-week-high of 31.54 and a 52-week-low of 14.48. Theravance Biopharma closed at $17.28 at the end of the last trading period.

Downgrades

B of A Securities downgraded the previous rating for Paramount Group Inc (NYSE:PGRE) from Neutral to Underperform. In the second quarter, Paramount Group showed an EPS of $0.23, compared to $0.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of 15.0 and a 52-week-low of 6.42. Paramount Group closed at $7.00 at the end of the last trading period.
According to UBS, the prior rating for Splunk Inc (NASDAQ:SPLK) was changed from Buy to Sell. For the second quarter, Splunk had an EPS of $0.33, compared to year-ago quarter EPS of $0.67. At the moment, the stock has a 52-week-high of 225.8944 and a 52-week-low of 93.92. Splunk closed at $215.83 at the end of the last trading period.
For Constellation Brands Inc (NYSE:STZ), Atlantic Equities downgraded the previous rating of Overweight to the current rating Neutral. For the second quarter, Constellation Brands had an EPS of $2.76, compared to year-ago quarter EPS of $2.72. At the moment, the stock has a 52-week-high of 208.55 and a 52-week-low of 104.28. Constellation Brands closed at $187.57 at the end of the last trading period.
According to JP Morgan, the prior rating for Invitae Corp (NYSE:NVTA) was changed from Overweight to Neutral. For the second quarter, Invitae had an EPS of $0.77, compared to year-ago quarter EPS of $0.52. The stock has a 52-week-high of 55.38 and a 52-week-low of 7.415. At the end of the last trading period, Invitae closed at $52.59.
For Livongo Health Inc (NASDAQ:LVGO), JP Morgan downgraded the previous rating of Overweight to the current rating Neutral. In the second quarter, Livongo Health showed an EPS of $0.11, compared to $0.46 from the year-ago quarter. The stock has a 52-week-high of 151.049 and a 52-week-low of 17.25. At the end of the last trading period, Livongo Health closed at $148.08.
For Albemarle Corp (NYSE:ALB), RBC Capital downgraded the previous rating of Sector Perform to the current rating Underperform. For the second quarter, Albemarle had an EPS of $0.86, compared to year-ago quarter EPS of $1.55. At the moment, the stock has a 52-week-high of 101.0 and a 52-week-low of 48.8901. Albemarle closed at $95.10 at the end of the last trading period.
KeyBanc downgraded the previous rating for Pentair PLC (NYSE:PNR) from Overweight to Sector Weight. For the second quarter, Pentair had an EPS of $0.59, compared to year-ago quarter EPS of $0.69. At the moment, the stock has a 52-week-high of 50.52 and a 52-week-low of 22.01. Pentair closed at $49.28 at the end of the last trading period.

Initiations

With a current rating of Equal-Weight, Stephens & Co. initiated coverage on West Pharmaceutical Services Inc (NYSE:WST). The price target seems to have been set at $300.00 for West Pharmaceutical Servs. For the second quarter, West Pharmaceutical Servs had an EPS of $1.25, compared to year-ago quarter EPS of $0.89. The current stock performance of West Pharmaceutical Servs shows a 52-week-high of 303.14 and a 52-week-low of 124.53. Moreover, at the end of the last trading period, the closing price was at $299.45.
With a current rating of Buy, Citigroup initiated coverage on PNM Resources Inc (NYSE:PNM). The price target seems to have been set at $51.00 for PNM Resources. In the second quarter, PNM Resources showed an EPS of $0.55, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of 56.14 and a 52-week-low of 27.08. PNM Resources closed at $45.50 at the end of the last trading period.
With a current rating of Buy, Deutsche Bank initiated coverage on 1Life Healthcare Inc (NASDAQ:ONEM). The price target seems to have been set at $37.00 for 1Life Healthcare. 1Life Healthcare earned $0.24 in the second quarter. The current stock performance of 1Life Healthcare shows a 52-week-high of 44.87 and a 52-week-low of 15.0. Moreover, at the end of the last trading period, the closing price was at $29.70.
UBS initiated coverage on VMware Inc (NYSE:VMW) with a Neutral rating. The price target for VMware is set to $155.00. VMware earned $1.81 in the second quarter, compared to $1.60 in the year-ago quarter. At the moment, the stock has a 52-week-high of 173.37 and a 52-week-low of 86.0. VMware closed at $155.04 at the end of the last trading period.
UBS initiated coverage on Veeva Systems Inc (NYSE:VEEV) with a Sell rating. The price target for Veeva Systems is set to $225.00. For the second quarter, Veeva Systems had an EPS of $0.72, compared to year-ago quarter EPS of $0.55. At the moment, the stock has a 52-week-high of 312.0 and a 52-week-low of 118.11. Veeva Systems closed at $308.84 at the end of the last trading period.
UBS initiated coverage on Oracle Corp (NYSE:ORCL) with a Neutral rating. The price target for Oracle is set to $62.00. For the first quarter, Oracle had an EPS of $0.93, compared to year-ago quarter EPS of $0.81. At the moment, the stock has a 52-week-high of 62.5999 and a 52-week-low of 39.71. Oracle closed at $60.97 at the end of the last trading period.
Morgan Stanley initiated coverage on New York Times Co (NYSE:NYT) with an Overweight rating. The price target for New York Times is set to $55.00. In the second quarter, New York Times showed an EPS of $0.18, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of 47.95 and a 52-week-low of 26.13. New York Times closed at $43.41 at the end of the last trading period.
For Intellia Therapeutics Inc (NASDAQ:NTLA), Wells Fargo initiated coverage, by setting the current rating at Overweight. Intellia Therapeutics earned $0.61 in the second quarter, compared to $0.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of 26.77 and a 52-week-low of 9.18. Intellia Therapeutics closed at $24.61 at the end of the last trading period.
UBS initiated coverage on ServiceNow Inc (NYSE:NOW) with a Buy rating. The price target for ServiceNow is set to $600.00. In the second quarter, ServiceNow showed an EPS of $1.23, compared to $0.71 from the year-ago quarter. The stock has a 52-week-high of 522.77 and a 52-week-low of 213.99. At the end of the last trading period, ServiceNow closed at $518.22.
HC Wainwright & Co. initiated coverage on Compass Pathways PLC (NASDAQ:CMPS) with a Buy rating. The price target for Compass Pathways is set to $65.00. The current stock performance of Compass Pathways shows a 52-week-high of 47.29 and a 52-week-low of 22.51. Moreover, at the end of the last trading period, the closing price was at $38.82.
With a current rating of Outperform, CICC initiated coverage on Niu Technologies (NASDAQ:NIU). The price target seems to have been set at $31.00 for Niu Technologies. In the second quarter, Niu Technologies showed an EPS of $0.10, compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of 28.4899 and a 52-week-low of 6.08. At the end of the last trading period, Niu Technologies closed at $27.37.
UBS initiated coverage on Microsoft Corp (NASDAQ:MSFT) with a Buy rating. The price target for Microsoft is set to $243.00. For the fourth quarter, Microsoft had an EPS of $1.46, compared to year-ago quarter EPS of $1.37. At the moment, the stock has a 52-week-high of 232.86 and a 52-week-low of 132.52. Microsoft closed at $222.86 at the end of the last trading period.
UBS initiated coverage on DocuSign Inc (NASDAQ:DOCU) with a Buy rating. The price target for DocuSign is set to $290.00. For the second quarter, DocuSign had an EPS of $0.17, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of 290.23 and a 52-week-low of 61.68. At the end of the last trading period, DocuSign closed at $238.21.
UBS initiated coverage on Citrix Systems Inc (NASDAQ:CTXS) with a Neutral rating. The price target for Citrix Systems is set to $146.00. For the second quarter, Citrix Systems had an EPS of $1.53, compared to year-ago quarter EPS of $1.21. At the moment, the stock has a 52-week-high of 173.56 and a 52-week-low of 97.45. Citrix Systems closed at $144.03 at the end of the last trading period.
UBS initiated coverage on Salesforce.com Inc (NYSE:CRM) with a Buy rating. The price target for Salesforce.com is set to $325.00. For the second quarter, Salesforce.com had an EPS of $1.44, compared to year-ago quarter EPS of $0.66. At the moment, the stock has a 52-week-high of 284.5 and a 52-week-low of 115.29. Salesforce.com closed at $266.76 at the end of the last trading period.
With a current rating of Buy, HC Wainwright & Co. initiated coverage on Humanigen Inc (NASDAQ:HGEN). The price target seems to have been set at $31.00 for Humanigen. Humanigen earned $0.16 in the second quarter, compared to $0.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of 33.95 and a 52-week-low of 3.4. Humanigen closed at $12.03 at the end of the last trading period.
With a current rating of Buy, Needham initiated coverage on Calix Inc (NYSE:CALX). The price target seems to have been set at $25.00 for Calix. Calix earned $0.14 in the second quarter, compared to $0.01 in the year-ago quarter. The stock has a 52-week-high of 22.69 and a 52-week-low of 5.61. At the end of the last trading period, Calix closed at $19.50.
Wedbush initiated coverage on Unity Software Inc (NYSE:U) with an Outperform rating. The price target for Unity Software is set to $125.00. The current stock performance of Unity Software shows a 52-week-high of 102.63 and a 52-week-low of 65.11. Moreover, at the end of the last trading period, the closing price was at $92.19.

Upgrades

升級

For AnaptysBio Inc (NASDAQ:ANAB), Guggenheim upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, AnaptysBio showed an EPS of $0.79, compared to $0.89 from the year-ago quarter. At the moment, the stock has a 52-week-high of 39.48 and a 52-week-low of 10.0. AnaptysBio closed at $17.76 at the end of the last trading period.
According to Loop Capital, the prior rating for American Eagle Outfitters Inc (NYSE:AEO) was changed from Sell to Hold. In the second quarter, American Eagle Outfitters showed an EPS of $0.03, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of 16.825 and a 52-week-low of 6.535. American Eagle Outfitters closed at $14.80 at the end of the last trading period.
According to UBS, the prior rating for Workday Inc (NASDAQ:WDAY) was changed from Sell to Neutral. In the second quarter, Workday showed an EPS of $0.84, compared to $0.44 from the year-ago quarter. The stock has a 52-week-high of 248.75 and a 52-week-low of 107.75. At the end of the last trading period, Workday closed at $232.90.
For AutoZone Inc (NYSE:AZO), Raymond James upgraded the previous rating of Outperform to the current rating Strong Buy. AutoZone earned $30.93 in the fourth quarter, compared to $20.95 in the year-ago quarter. The current stock performance of AutoZone shows a 52-week-high of 1274.4075 and a 52-week-low of 684.91. Moreover, at the end of the last trading period, the closing price was at $1165.71.
JP Morgan upgraded the previous rating for NIO Inc (NYSE:NIO) from Neutral to Overweight. NIO earned $0.15 in the second quarter, compared to $0.45 in the year-ago quarter. The current stock performance of NIO shows a 52-week-high of 22.59 and a 52-week-low of 1.36. Moreover, at the end of the last trading period, the closing price was at $21.61.
According to Jefferies, the prior rating for Beacon Roofing Supply Inc (NASDAQ:BECN) was changed from Hold to Buy. For the third quarter, Beacon Roofing Supply had an EPS of $1.01, compared to year-ago quarter EPS of $0.32. The stock has a 52-week-high of 37.06 and a 52-week-low of 11.665. At the end of the last trading period, Beacon Roofing Supply closed at $35.43.
For Theravance Biopharma Inc (NASDAQ:TBPH), Morgan Stanley upgraded the previous rating of Equal-Weight to the current rating Overweight. Theravance Biopharma earned $1.00 in the second quarter, compared to $0.72 in the year-ago quarter. At the moment, the stock has a 52-week-high of 31.54 and a 52-week-low of 14.48. Theravance Biopharma closed at $17.28 at the end of the last trading period.

為AnaptysBio Inc.(納斯達克：Anab)，Guggenheim將之前的中性評級上調至當前評級買入。第二季度，AnaptysBio的每股收益為0.79美元，而去年同期為0.89美元。目前，該股的52周高點為39.48，52周低點為10.0。AnaptysBio上交易日尾盤報17.76美元。
根據Loop Capital的説法，之前的評級美國鷹牌服裝公司(紐約證券交易所：AEO)已從賣出更改為持有。第二季度，American Eagle Outfitters的每股收益為0.03美元，而去年同期為0.39美元。目前，該股的52周高點為16.825，52周低點為6.535。American Eagle Outfitters上一交易期尾盤報14.80美元。
根據瑞銀的説法，之前的評級為Workday Inc.(納斯達克：WDAY)從賣出改為中性。第二季度，Workday的每股收益為0.84美元，而去年同期為0.44美元。該股目前的52周高點為248.75，52周低點為107.75。上一交易期尾盤，Workday收報232.90美元。
為AutoZone Inc.(紐約證券交易所：偶氮)，Raymond James將之前的評級上調為強於大盤，至目前的評級為強力買入。AutoZone第四季度的利潤為30.93美元，而去年同期為20.95美元。目前AutoZone的股票表現顯示，52周高點為1274.4075，52周低點為684.91。此外，在上一交易期結束時，收盤價為1165.71美元。
摩根大通上調了之前的評級為蔚來(紐約證券交易所：蔚來)從中性到增持。蔚來第二季度的利潤為0.15美元，而去年同期為0.45美元。蔚來目前的股票表現顯示，52周高點為22.59，52周低點為1.36.此外，在上一交易期結束時，收盤價為21.61美元。
據傑富瑞稱，之前的評級為Beacon屋面供應有限公司(納斯達克：BECN)已從持有更改為買入。第三季度，Beacon Roofing Supply的每股收益為1.01美元，而去年同期為0.32美元。該股的52周高點為37.06點，52周低點為11.665點。上一交易期尾盤，Beacon Roofing Supply收於35.43美元。
為Theravance Biophma Inc.(納斯達克：TBPH)，摩根士丹利將此前評級為持平上調至當前評級增持。Theravance Biophma第二季度的利潤為1.00美元，而去年同期為0.72美元。目前，該股的52周高點為31.54，52周低點為14.48。Theravance Biophma上一交易期尾盤報17.28美元。

Downgrades

評級下調

B of A Securities downgraded the previous rating for Paramount Group Inc (NYSE:PGRE) from Neutral to Underperform. In the second quarter, Paramount Group showed an EPS of $0.23, compared to $0.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of 15.0 and a 52-week-low of 6.42. Paramount Group closed at $7.00 at the end of the last trading period.
According to UBS, the prior rating for Splunk Inc (NASDAQ:SPLK) was changed from Buy to Sell. For the second quarter, Splunk had an EPS of $0.33, compared to year-ago quarter EPS of $0.67. At the moment, the stock has a 52-week-high of 225.8944 and a 52-week-low of 93.92. Splunk closed at $215.83 at the end of the last trading period.
For Constellation Brands Inc (NYSE:STZ), Atlantic Equities downgraded the previous rating of Overweight to the current rating Neutral. For the second quarter, Constellation Brands had an EPS of $2.76, compared to year-ago quarter EPS of $2.72. At the moment, the stock has a 52-week-high of 208.55 and a 52-week-low of 104.28. Constellation Brands closed at $187.57 at the end of the last trading period.
According to JP Morgan, the prior rating for Invitae Corp (NYSE:NVTA) was changed from Overweight to Neutral. For the second quarter, Invitae had an EPS of $0.77, compared to year-ago quarter EPS of $0.52. The stock has a 52-week-high of 55.38 and a 52-week-low of 7.415. At the end of the last trading period, Invitae closed at $52.59.
For Livongo Health Inc (NASDAQ:LVGO), JP Morgan downgraded the previous rating of Overweight to the current rating Neutral. In the second quarter, Livongo Health showed an EPS of $0.11, compared to $0.46 from the year-ago quarter. The stock has a 52-week-high of 151.049 and a 52-week-low of 17.25. At the end of the last trading period, Livongo Health closed at $148.08.
For Albemarle Corp (NYSE:ALB), RBC Capital downgraded the previous rating of Sector Perform to the current rating Underperform. For the second quarter, Albemarle had an EPS of $0.86, compared to year-ago quarter EPS of $1.55. At the moment, the stock has a 52-week-high of 101.0 and a 52-week-low of 48.8901. Albemarle closed at $95.10 at the end of the last trading period.
KeyBanc downgraded the previous rating for Pentair PLC (NYSE:PNR) from Overweight to Sector Weight. For the second quarter, Pentair had an EPS of $0.59, compared to year-ago quarter EPS of $0.69. At the moment, the stock has a 52-week-high of 50.52 and a 52-week-low of 22.01. Pentair closed at $49.28 at the end of the last trading period.

B of A Securities下調前一次評級為派拉蒙集團公司(紐約證券交易所：PGRE)從中性到表現不佳。派拉蒙集團第二季度每股收益為0.23美元，而去年同期為0.23美元。目前，該股的52周高點為15.0，52周低點為6.42。派拉蒙集團上一交易期尾盤報7.00美元。
根據瑞銀的説法，之前的評級為Splunk Inc.(納斯達克：SPLK)從買入更改為賣出。第二季度，Splunk的每股收益為0.33美元，而去年同期為0.67美元。目前，該股的52周高點為225.8944，52周低點為93.92.Splunk上一交易期尾盤報215.83美元。
為星座品牌公司(紐約證券交易所：STZ)，大西洋證券將之前的增持評級下調至目前的評級中性。第二季度，星座品牌的每股收益為2.76美元，而去年同期為2.72美元。目前，該股的52周高點為208.55，52周低點為104.28。星座品牌上一交易期尾盤報187.57美元。
據摩根大通稱，之前的評級為Invitae公司(紐約證券交易所：NVTA)從增持改為中性。第二季度，Invitae的每股收益為0.77美元，而去年同期為0.52美元。該股的52周高點為55.38點，52周低點為7.415點。上一交易期尾盤，Invitae收報52.59美元。
為Livongo Health Inc.(納斯達克：LVGO)，摩根大通將之前的評級下調至增持至當前評級中性。在第二季度，Livongo Health顯示每股收益為0.11美元，而去年同期為0.46美元。該股目前的52周高點為151.049，52周低點為17.25.上一交易期結束時，Livongo Health收於148.08美元。
為Albemarle公司(紐約證券交易所：阿爾布)，RBC Capital將之前對Sector Performance的評級下調至當前評級Under Performance。第二季度，Albemarle的每股收益為0.86美元，而去年同期為1.55美元。目前，該股的52周高點為101.0，52周低點為48.8901。Albemarle上交易日尾盤報95.10美元。
KeyBanc下調了之前的評級賓泰PLC(紐約證券交易所：PNR)從增持到板塊權重。第二季度，Pentair的每股收益為0.59美元，而去年同期為0.69美元。目前，該股的52周高點為50.52點，52周低點為22.01點。Pentair在上一交易期結束時收於49.28美元。

Initiations

啟蒙行動

With a current rating of Equal-Weight, Stephens & Co. initiated coverage on West Pharmaceutical Services Inc (NYSE:WST). The price target seems to have been set at $300.00 for West Pharmaceutical Servs. For the second quarter, West Pharmaceutical Servs had an EPS of $1.25, compared to year-ago quarter EPS of $0.89. The current stock performance of West Pharmaceutical Servs shows a 52-week-high of 303.14 and a 52-week-low of 124.53. Moreover, at the end of the last trading period, the closing price was at $299.45.
With a current rating of Buy, Citigroup initiated coverage on PNM Resources Inc (NYSE:PNM). The price target seems to have been set at $51.00 for PNM Resources. In the second quarter, PNM Resources showed an EPS of $0.55, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of 56.14 and a 52-week-low of 27.08. PNM Resources closed at $45.50 at the end of the last trading period.
With a current rating of Buy, Deutsche Bank initiated coverage on 1Life Healthcare Inc (NASDAQ:ONEM). The price target seems to have been set at $37.00 for 1Life Healthcare. 1Life Healthcare earned $0.24 in the second quarter. The current stock performance of 1Life Healthcare shows a 52-week-high of 44.87 and a 52-week-low of 15.0. Moreover, at the end of the last trading period, the closing price was at $29.70.
UBS initiated coverage on VMware Inc (NYSE:VMW) with a Neutral rating. The price target for VMware is set to $155.00. VMware earned $1.81 in the second quarter, compared to $1.60 in the year-ago quarter. At the moment, the stock has a 52-week-high of 173.37 and a 52-week-low of 86.0. VMware closed at $155.04 at the end of the last trading period.
UBS initiated coverage on Veeva Systems Inc (NYSE:VEEV) with a Sell rating. The price target for Veeva Systems is set to $225.00. For the second quarter, Veeva Systems had an EPS of $0.72, compared to year-ago quarter EPS of $0.55. At the moment, the stock has a 52-week-high of 312.0 and a 52-week-low of 118.11. Veeva Systems closed at $308.84 at the end of the last trading period.
UBS initiated coverage on Oracle Corp (NYSE:ORCL) with a Neutral rating. The price target for Oracle is set to $62.00. For the first quarter, Oracle had an EPS of $0.93, compared to year-ago quarter EPS of $0.81. At the moment, the stock has a 52-week-high of 62.5999 and a 52-week-low of 39.71. Oracle closed at $60.97 at the end of the last trading period.
Morgan Stanley initiated coverage on New York Times Co (NYSE:NYT) with an Overweight rating. The price target for New York Times is set to $55.00. In the second quarter, New York Times showed an EPS of $0.18, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of 47.95 and a 52-week-low of 26.13. New York Times closed at $43.41 at the end of the last trading period.
For Intellia Therapeutics Inc (NASDAQ:NTLA), Wells Fargo initiated coverage, by setting the current rating at Overweight. Intellia Therapeutics earned $0.61 in the second quarter, compared to $0.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of 26.77 and a 52-week-low of 9.18. Intellia Therapeutics closed at $24.61 at the end of the last trading period.
UBS initiated coverage on ServiceNow Inc (NYSE:NOW) with a Buy rating. The price target for ServiceNow is set to $600.00. In the second quarter, ServiceNow showed an EPS of $1.23, compared to $0.71 from the year-ago quarter. The stock has a 52-week-high of 522.77 and a 52-week-low of 213.99. At the end of the last trading period, ServiceNow closed at $518.22.
HC Wainwright & Co. initiated coverage on Compass Pathways PLC (NASDAQ:CMPS) with a Buy rating. The price target for Compass Pathways is set to $65.00. The current stock performance of Compass Pathways shows a 52-week-high of 47.29 and a 52-week-low of 22.51. Moreover, at the end of the last trading period, the closing price was at $38.82.
With a current rating of Outperform, CICC initiated coverage on Niu Technologies (NASDAQ:NIU). The price target seems to have been set at $31.00 for Niu Technologies. In the second quarter, Niu Technologies showed an EPS of $0.10, compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of 28.4899 and a 52-week-low of 6.08. At the end of the last trading period, Niu Technologies closed at $27.37.
UBS initiated coverage on Microsoft Corp (NASDAQ:MSFT) with a Buy rating. The price target for Microsoft is set to $243.00. For the fourth quarter, Microsoft had an EPS of $1.46, compared to year-ago quarter EPS of $1.37. At the moment, the stock has a 52-week-high of 232.86 and a 52-week-low of 132.52. Microsoft closed at $222.86 at the end of the last trading period.
UBS initiated coverage on DocuSign Inc (NASDAQ:DOCU) with a Buy rating. The price target for DocuSign is set to $290.00. For the second quarter, DocuSign had an EPS of $0.17, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of 290.23 and a 52-week-low of 61.68. At the end of the last trading period, DocuSign closed at $238.21.
UBS initiated coverage on Citrix Systems Inc (NASDAQ:CTXS) with a Neutral rating. The price target for Citrix Systems is set to $146.00. For the second quarter, Citrix Systems had an EPS of $1.53, compared to year-ago quarter EPS of $1.21. At the moment, the stock has a 52-week-high of 173.56 and a 52-week-low of 97.45. Citrix Systems closed at $144.03 at the end of the last trading period.
UBS initiated coverage on Salesforce.com Inc (NYSE:CRM) with a Buy rating. The price target for Salesforce.com is set to $325.00. For the second quarter, Salesforce.com had an EPS of $1.44, compared to year-ago quarter EPS of $0.66. At the moment, the stock has a 52-week-high of 284.5 and a 52-week-low of 115.29. Salesforce.com closed at $266.76 at the end of the last trading period.
With a current rating of Buy, HC Wainwright & Co. initiated coverage on Humanigen Inc (NASDAQ:HGEN). The price target seems to have been set at $31.00 for Humanigen. Humanigen earned $0.16 in the second quarter, compared to $0.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of 33.95 and a 52-week-low of 3.4. Humanigen closed at $12.03 at the end of the last trading period.
With a current rating of Buy, Needham initiated coverage on Calix Inc (NYSE:CALX). The price target seems to have been set at $25.00 for Calix. Calix earned $0.14 in the second quarter, compared to $0.01 in the year-ago quarter. The stock has a 52-week-high of 22.69 and a 52-week-low of 5.61. At the end of the last trading period, Calix closed at $19.50.
Wedbush initiated coverage on Unity Software Inc (NYSE:U) with an Outperform rating. The price target for Unity Software is set to $125.00. The current stock performance of Unity Software shows a 52-week-high of 102.63 and a 52-week-low of 65.11. Moreover, at the end of the last trading period, the closing price was at $92.19.

目前評級為等權重，Stephens&Co.在西部藥業服務公司(紐約證券交易所：WST)。西方製藥公司的目標價格似乎被設定在300.00美元。第二季度，West Pharmtics Serv的每股收益為1.25美元，而去年同期為0.89美元。目前西部藥業SERV的股票表現顯示，52周高點為303.14，52周低點為124.53。此外，在上一交易期結束時，收盤價為299.45美元。
由於目前的評級為買入，花旗集團在PNM Resources Inc.(紐約證券交易所：PNM)。PNM Resources的目標價似乎被設定在51.00美元。第二季度，PNM Resources顯示每股收益為0.55美元，而去年同期為0.37美元。目前，該股的52周高點為56.14，52周低點為27.08。PNM Resources上一交易期尾盤報45.50美元。
目前評級為買入，德意志銀行在1人壽保健公司(納斯達克：ONEM)。1Life Healthcare的目標價似乎被設定在37.00美元。1Life Healthcare第二季度盈利0.24美元。目前1Life Healthcare的股票表現顯示，52周高點為44.87，52周低點為15.0。此外，在上一交易期結束時，收盤價為29.70美元。
瑞銀在以下時間開始承保VMware Inc.(紐約證券交易所：大眾汽車)，評級為中性。VMware的目標價定為155.00美元。VMware第二季度的利潤為1.81美元，而去年同期為1.60美元。目前，該股的52周高點為173.37，52周低點為86.0.Vmware上一交易期尾盤報155.04美元。
瑞銀在以下時間開始承保Veeva系統公司(紐約證券交易所：Veev)，並給予賣出評級。Veeva Systems的目標價定為225.00美元。第二季度，Veeva Systems的每股收益為0.72美元，而去年同期為0.55美元。目前，該股的52周高點為312.0，52周低點為118.11。Veeva Systems上一交易期尾盤報308.84美元。
瑞銀在以下時間開始承保甲骨文(紐約證券交易所：甲骨文)，評級為中性。甲骨文的目標價設為62.00美元。甲骨文第一季度每股收益為0.93美元，而去年同期為0.81美元。目前，該股的52周高點為62.5999，52周低點為39.71.甲骨文上一交易期尾盤報60.97美元。
摩根士丹利發起了關於紐約時報公司(紐約證券交易所：《紐約時報》)，評級超重。《紐約時報》的目標價定為55.00美元。第二季度，《紐約時報》公佈的每股收益為0.18美元，而去年同期為0.17美元。目前，該股的52周高點為47.95，52周低點為26.13。紐約時報上交易日尾盤報43.41美元。
為Intellia治療公司(納斯達克：NTLA)，富國銀行通過將當前評級設置為增持來啟動覆蓋範圍。Intellia治療公司第二季度的利潤為0.61美元，而去年同期為0.56美元。目前，該股的52周高點為26.77，52周低點為9.18。Intellia Treeutics在上一交易期結束時收於24.61美元。
瑞銀在以下時間開始承保現在服務公司(紐約證券交易所：現在)，評級為買入。ServiceNow的目標價定為600.00美元。在第二季度，ServiceNow顯示每股收益為1.23美元，而去年同期為0.71美元。該股目前的52周高點為522.77，52周低點為213.99。在上個交易期結束時，ServiceNow收於518.22美元。
HC Wainwright&Co.開始承保指南針路徑PLC(納斯達克：中成藥)，評級為買入。Compass Path的目標價設定為65.00美元。目前，Compass Path的股票表現顯示，52周高點為47.29，52周低點為22.51。此外，在上一交易期結束時，收盤價為38.82美元。
目前評級為跑贏大盤，中金公司於小牛電動(納斯達克：牛牛)。小牛電動的目標價似乎被設定在31美元。第二季度，小牛電動的每股收益為0.1美元，而去年同期為0.1美元。該股目前的52周高點為28.4899，52周低點為6.08.上一交易日尾盤，小牛電動收報27.37美元。
瑞銀在以下時間開始承保微軟(納斯達克：MSFT)，評級為買入。微軟的目標價定為243.00美元。微軟第四季度每股收益為1.46美元，而去年同期為1.37美元。目前，該股的52周高點為232.86，52周低點為132.52。微軟上交易日尾盤報222.86美元。
瑞銀在以下時間開始承保DocuSign Inc.(納斯達克：文檔)，評級為買入。DocuSign的目標價定為290.00美元。第二季度，DocuSign的每股收益為0.17美元，而去年同期為0.01美元。該股的52周高點為290.23，52周低點為61.68.上一交易日尾盤，DocuSign收於238.21美元。
瑞銀在以下時間開始承保Citrix Systems Inc.(納斯達克：CTXS)，評級為中性。Citrix Systems的目標價定為146.00美元。第二季度，Citrix Systems的每股收益為1.53美元，而去年同期為1.21美元。目前，該股的52周高點為173.56，52周低點為97.45.Citrix Systems上一交易期尾盤報144.03美元。
瑞銀在以下時間開始承保Salesforce(紐約證券交易所：CRM)，評級為買入。Salesforce.com的目標價設定為325.00美元。Salesforce.com第二季度每股收益為1.44美元，而去年同期為0.66美元。目前，該股的52周高點為284.5，52周低點為115.29。Salesforce.com上一交易期尾盤報266.76美元。
目前評級為買入，HC Wainwright&Co.在Humanigen Inc.(納斯達克：HGEN)。Humanigen的目標價似乎被設定在31.00美元。Humanigen第二季度的利潤為0.16美元，而去年同期為0.03美元。目前，該股的52周高點為33.95，52周低點為3.4。Humanigen上一交易期尾盤報12.03美元。
在目前評級為買入的情況下，Needham在卡利克斯公司(紐約證券交易所：加爾克斯)。卡利克斯的目標價似乎被設定在25.00美元。卡利克斯第二季度的利潤為0.14美元，而去年同期為0.01美元。該股目前的52周高點為22.69，52周低點為5.61。上一交易期尾盤，卡利克斯收報19.50美元。
韋德布什發起了關於Unity Software Inc.(紐約證券交易所：U)，表現優於大盤。聯合軟件的目標價格定為125.00美元。聯合軟件目前的股票表現顯示，52周高點為102.63，52周低點為65.11.此外，在上一交易期結束時，收盤價為92.19美元。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

Benzinga's Top Upgrades, Downgrades For October 14, 2020

Benzinga's Top Upgrades, Downgrades For October 14, 2020

Upgrades

Downgrades

Initiations

Upgrades

升級

Downgrades

評級下調

Initiations

啟蒙行動

風險及免責聲明

聲明